pharmacokinetic profile
Plasma pharmacokinetic profile of fluralaner (Bravecto™) and ivermectin following concurrent administration to dogs
... the pharmacokinetic profile of ivermectin was investigated when administered concurrently with ...For pharmacokinetic characterization over time, fluralaner and ivermectin were administered at high ...
5
Pharmacokinetic profile of rutin after intramuscular administration in rats favours its in vivo anti-inflammatory activity in carrageenaninduced rodent model of inflammation
... to pharmacokinetic profile of rutin after intramuscular administration along with in vivo evaluation of its anti-inflammatory activity in animals, present study was planned to generate data related to ...
8
Pharmacokinetic profile of defibrotide in patients with renal impairment
... PK profile of defibrotide in subjects with severe renal disease/ESRD not dependent on dialysis with that in healthy matching ...tolerability profile of defibrotide in renal-impaired ...
11
Pharmacokinetic profile of an intradeltoid diclofenac injection in obese Indian volunteers
... The pharmacokinetic parameters measured include the observed maximum plasma concentration (C max ), time to reach C max (T max ), and the area under the plasma concentra- tion-time curve from 0 hours to the time ...
6
Pretreatment with trikatu augments pharmacokinetic profile and bioavailability of orally administered levofloxacin in goat
... 1994). Pharmacokinetic studies of levofloxacin have been reported, following intravenous administration in cats (Albarellos et ...this, pharmacokinetic studies of levofloxacin have also been reported, ...
6
Population pharmacokinetic modeling of the Qishe pill in three major traditional Chinese medicine defined constitutional types of healthy Chinese subjects: study protocol for a randomized controlled trial
... population pharmacokinetic profile of the Qishe pill and compare its metabolic rate in the three major constitution types (Qi-Deficiency, Yin-Deficiency and Blood-Stasis) to address major challenges to ...
10
Development and Validation of an In Vitro and In Vivo Correlation Model in Rabbit for Topiramate Extended Release Capsules
... vivo pharmacokinetic profile of the immediate release suspension and different extended release formulations were investigated in a rabbit model after single oral administration of topiramate at a dose of ...
9
A critical appraisal of the misoprostol removable, controlled-release vaginal delivery system of labor induction
... Powers et al studied the pharmacokinetic profile of the MVI with different doses on nonpregnant women and showed in their study that after oral administration of 200 µ g of m[r] ...
11
DEVELOPMENT AND BIOEQUIVALENCE STUDY OF OLANZAPINE 10mg TABLETS
... Olanzapine Tablets and compare pharmacokinetic profile of Zyprexa 10 mg film-coated tablets, Zyprexa Velotabs 10 mg orodispersible tablets and Olanzapine 10mg tablets. Multi media dissolution studies in ...
6
Phase 1B/2 study of the HSP90 inhibitor AUY922 plus trastuzumab in metastatic HER2-positive breast cancer patients who have progressed on trastuzumab-based regimen
... and pharmacokinetic profile of AUY922 in combination with trastuzumab in patients with locally advanced or metastatic HER2-positive breast cancer previously treated with chemotherapy and anti-HER2 ...
13
Bioequivalence of two formulations of montelukast sodium 4 mg oral granules in healthy adults
... the pharmacokinetic profile and safety of Sandoz generic montelukast 4 mg oral granules relative to Singulair® mini (Merck, Sharp & ...and pharmacokinetic parameters calculated from the drug ...
5
Physiological and pharmacokinetic effects of oral 1,3-dimethylamylamine administration in men
... safety profile of DMAA based solely on case reports would be problematic, in particu- lar when accepting testimony from patients in uncon- trolled environment, potentially under the influence of alcohol and other ...
10
Randomized, open-label, comparative phase IV study on the bioavailability of Ciclosporin Pro (Teva) versus Sandimmun® Optoral (Novartis) under fasting versus fed conditions in patients with stable renal transplants
... the pharmacokinetic profile of the two cyclosporine containing formulations Ciclosporin Pro (gel-based emulsion) and Sandimmun®Optoral (microemul- sion) in stable renal transplant ...
11
Optimized zein nanospheres for improved oral bioavailability of atorvastatin
... the pharmacokinetic profile and increase the bioavailability of ATR by more than 3-fold in comparison with the oral suspension and the commercially available ...
11
Pharmacokinetic Interactions of Glipizide with Esomeprazole in Normal, Diabetic and Ulcerative Rats
... (MD) pharmacokinetic studies were performed for glipizide and esomeprazole in normal, diabetic and ulcerative ...and pharmacokinetic parameters were ...on pharmacokinetic profile of ...
7
Lisdexamfetamine in the treatment of adolescents and children with attention-deficit/hyperactivity disorder
... the pharmacokinetic profile, efficacy, and safety of lisdexamfetamine dimesylate for the treatment of attention-deficit/hyperactivity disorder in children and, more recently, in ...
16
The pharmacokinetics and safety of an intraoperative bupivacaine-collagen implant (XaraColl<sup>®</sup>) for postoperative analgesia in women following total abdominal hysterectomy
... The pharmacokinetic profile displayed a double peak in bupivacaine concentration with the second peak occurring up to 24 hours after the first and at a generally higher ...
9
Development of nanoemulsion for efficient brain parenteral delivery of cefuroxime: designs, characterizations, and pharmacokinetics
... release profile of CLN followed a sustained-release pattern, and MTT assay revealed that CLN was nontoxic at the concentration of 10 µ ...The pharmacokinetic profile of CLN showed significantly ...
14
A systematic review of new advances in the management of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): focus on galsulfase
... Pharmacokinetic profile of recombinant human N-acetylgalactosamine 4-sulphatase enzyme replacement therapy in patients with mucopolysaccharidosis VI (Maroteaux-Lamy syndrome):[r] ...
10
The intravenous and oral pharmacokinetics of lotilaner in dogs
... The pharmacokinetic properties of lotilaner (Credelio™) were investigated in a number of studies. Following a single intravenous administration, lotilaner had a very low clear- ance (0.18 l/kg/day) and high ...
8